Lin YC - Search Results

1

An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancer.

Lin YC, Chang HK, Shen WC, Chen JS, Wang HM. Lin YC, et al. Anticancer Drugs. 2007 Nov;18(10):1213-9. doi: 10.1097/CAD.0b013e3282ee3af2. Anticancer Drugs. 2007. PMID: 17893523 Clinical Trial.

2

Reduced maintenance of complete protection from emesis for women during chemotherapy cycles.

Liaw CC, Chang HK, Liau CT, Huang JS, Lin YC, Chen JS. Liaw CC, et al. Among authors: lin yc. Am J Clin Oncol. 2003 Feb;26(1):12-5. doi: 10.1097/00000421-200302000-00003. Am J Clin Oncol. 2003. PMID: 12576917 Clinical Trial.

3

The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers.

Lin YC, Wu Chou YH, Liao IC, Cheng AJ. Lin YC, et al. Cancer Lett. 2003 Feb 28;191(1):93-9. doi: 10.1016/s0304-3835(02)00545-1. Cancer Lett. 2003. PMID: 12609714

4

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

Cheung YC, Chen SC, Su MY, See LC, Hsueh S, Chang HK, Lin YC, Tsai CS. Cheung YC, et al. Among authors: lin yc. Breast Cancer Res Treat. 2003 Mar;78(1):51-8. doi: 10.1023/a:1022153327339. Breast Cancer Res Treat. 2003. PMID: 12611457

5

Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients.

Lin YC, Chen SC, Hsueh S, Lo YF, Chow-Wu YH, Liaw IC, Cheng AJ. Lin YC, et al. Cancer Sci. 2003 Jan;94(1):99-102. doi: 10.1111/j.1349-7006.2003.tb01359.x. Cancer Sci. 2003. PMID: 12708482 Free PMC article.

6

A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas.

Chen JS, Yang TS, Lin YC, Jan YY. Chen JS, et al. Among authors: lin yc. Jpn J Clin Oncol. 2003 Jul;33(7):353-6. doi: 10.1093/jjco/hyg070. Jpn J Clin Oncol. 2003. PMID: 12949062 Clinical Trial.

7

Mitomycin C (MMC) with weekly 24-hour infusions of high-dose 5-fluorouracil and leucovorin in patients with advanced gastric cancer.

Chen JS, Lin YC, Liau CT, Wang CH, Liaw CC. Chen JS, et al. Among authors: lin yc. Chang Gung Med J. 2003 Jun;26(6):433-9. Chang Gung Med J. 2003. PMID: 12956290 Free article.

8

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.

Yang TS, Chang HK, Chen JS, Lin YC, Liau CT, Chang WC. Yang TS, et al. Among authors: lin yc. J Gastroenterol. 2004;39(4):362-9. doi: 10.1007/s00535-003-1303-8. J Gastroenterol. 2004. PMID: 15168248

9

A modified low-dose regimen of mitoxantrone and prednisolone in patients with androgen-independent prostate cancer.

Sheen WC, Chen JS, Wang HM, Yang TS, Liaw CC, Lin YC. Sheen WC, et al. Among authors: lin yc. Jpn J Clin Oncol. 2004 Jun;34(6):337-41. doi: 10.1093/jjco/hyh064. Jpn J Clin Oncol. 2004. PMID: 15333686

10

Phase I dose escalation study of oxaliplatin combined with oral tegafur-uracil and leucovorin in patients with advanced gastric cancer.

Chen JS, Huang JS, Yang TS, Lin YC, Wang HM, Liau CT, Rau KM. Chen JS, et al. Among authors: lin yc. Anticancer Drugs. 2005 Jan;16(1):47-51. doi: 10.1097/00001813-200501000-00006. Anticancer Drugs. 2005. PMID: 15613903 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,463 results

Search Page

Filters